Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning
暂无分享,去创建一个
A. Tordai | T. Masszi | P. Reményi | Á. Bátai | H. Andrikovics | K. Rajczy | A. Bors | A. Szilvási | A. Barta | K. P. Kiss | K. Balassa | D. Inotai | É. Torbágyi | L. Lengyel | K. Kiss